tiprankstipranks
BLPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsBLPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
9M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
9M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
9M ago
Bellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease
PremiumPress ReleasesBellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease
1y ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1y ago
Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial Results
PremiumPress Releases
Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial Results
1y ago
Bellerophon Therapeutics Receives IND Clearance from China NMPA to Conduct Phase 3 Clinical Trial in China for INOpulse® in Fibrotic Interstitial Lung Disease
PremiumPress ReleasesBellerophon Therapeutics Receives IND Clearance from China NMPA to Conduct Phase 3 Clinical Trial in China for INOpulse® in Fibrotic Interstitial Lung Disease
1y ago
Bellerophon: Last patient enrolled in INOpulse study for treatment of fILD
PremiumThe Fly
Bellerophon: Last patient enrolled in INOpulse study for treatment of fILD
2y ago
Bellerophon Therapeutics Announces Completion of Enrollment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease
PremiumPress Releases
Bellerophon Therapeutics Announces Completion of Enrollment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100